Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism

• Conditions: Rheumatism
• Interventions: Other: questionnaires

• Registration Number: NCT04723407
• Lead Sponsor: University Hospital, Limoges

Brief Summary

Patients with chronic inflammatory rheumatism (RIC) or autoimmune diseases, rheumatoid arthritis and spondyloarthritis, are regularly monitored in consultation as part of a "treat to target" strategy with rapid adaptation of treatments to the activity of their disease. according to French recommendations.

They are treated with immunosuppressive drugs: disease-modifying treatments with very often methotrexate, associated with biotherapies or targeted therapies (JAK inhibitors) They can also be treated transiently or over the long term with corticosteroids. These treatments expose them to greater infectious risks, especially with regard to COVID19.

The objective is on the one hand to assess the impact of the Covid 19 pandemic on general state of health of these patients and the evolution of their disease and on the other hand to prioritize the optimal care of these patients by including in the context of maintaining the pandemic reduction rules, modern telemedicine technologies.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-01
• Study First Submitted: 2021-01-22
• Study First Submitted QC: 2021-01-22
• Last Update Submitted: 2021-01-24
• Study First Posted: 2021-01-25
• Last Update Posted: 2021-01-26
• Study Start: 2021-02-01
• Primary Completion: 2022-01-01
• Study Completion: 2022-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 950

Inclusion Criteria

All patients with chronic inflammatory rheumatism followed in the rheumatology department of the CHU de Limoges.

Exclusion Criteria

Patients who object to the use of their data.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Exposed patients	questionnaires	Those who had the management strategy implemented by the service during confinement
Unexposed patients	questionnaires	Those who could not benefit from this strategy

Primary Outcome Measures

Name	Time	Method
post-traumatic stress	Day 1	Presence or absence of post-traumatic stress disorder due to the COVID19 pandemic assessed by the Post-traumatic stress disorder Check-list version DSM-5 (PCL-5)

Trial Locations

Locations (1)

Département de Rhumatologie; 🇫🇷 Limoges, France